Loading clinical trials...
Loading clinical trials...
A PHASE 1, OPEN-LABEL, MULTIPLE DOSE STUDY TO INVESTIGATE THE IMPACT OF PF 08653944 ON GASTRIC EMPTYING IN ADULT PARTICIPANTS WITH OVERWEIGHT OR OBESITY
Conditions
Interventions
PF-08653944
Acetaminophen
Locations
1
United States
Pfizer Clinical Research Unit - New Haven
New Haven, Connecticut, United States
Start Date
March 31, 2026
Primary Completion Date
January 27, 2027
Completion Date
January 27, 2027
Last Updated
April 23, 2026
NCT07037459
NCT07351045
NCT07244458
NCT05746039
NCT07395687
NCT07311850
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions